当前位置：
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The atopic dermatitis market
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2017-11-06 , DOI: 10.1038/nrd.2017.192 Eleni Pantazi , Gianluca Valenza , Manuela Hess , Bashar Hamad
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2017-11-06 , DOI: 10.1038/nrd.2017.192 Eleni Pantazi , Gianluca Valenza , Manuela Hess , Bashar Hamad
The atopic dermatitis market
中文翻译：
特应性皮炎市场
特应性皮炎市场
更新日期：2017-11-10
The atopic dermatitis market, Published online: 06 November 2017; doi:10.1038/nrd.2017.192
NatureArticleSnippet(type=short-summary, markup=The market for atopic dermatitis therapies is dominated by topical corticosteroids, but is poised to change with the recent approvals of dupilumab and crisaborole, as well as other drugs in clinical development.
中文翻译：
特应性皮炎市场
特应性皮炎市场
特应性皮炎市场，在线发布：2017年11月6日; doi：10.1038 / nrd.2017.192
NatureArticleSnippet（type = short-summary，markup =特应性皮炎疗法的市场以局部皮质类固醇为主，但随着dupilumab和crisaborole以及最近在临床开发中使用的其他药物的最新批准，市场可能会发生变化。
京公网安备 11010802027423号